CHD1 deletion often co-occurs with missense mutations in SPOP (speckle-type BTB/POZ protein) and defines a new molecular subtype of prostate cancer, characterized by increased DNA methylation and homogeneous gene expression patterns (60). Here, SPOP is linked to prostate carcinoma.